HNWAG
ABBV icon

High Net Worth Advisory Group’s AbbVie ABBV Stock Holding History

High Net Worth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.88M Sell
45,441
-60
-0.1% -$13.3K 2.31% 8
2025
Q4 		$10.4M Sell
45,501
-17
-0% -$3.87K 2.4% 8
2025
Q3 		$10.5M Sell
45,518
-454
-1% -$92.5K 2.54% 7
2025
Q2 		$8.53M Sell
45,972
-40
-0.1% -$7.43K 2.26% 8
2025
Q1 		$9.64M Buy
46,012
+1
+0% +$194 2.72% 8
2024
Q4 		$8.18M Sell
46,011
-563
-1% -$104K 2.28% 8
2024
Q3 		$9.2M Hold
46,574
– – 2.52% 8
2024
Q2 		$7.99M Buy
46,574
+1
+0% +$166 2.42% 8
2024
Q1 		$8.48M Buy
46,573
+2,600
+6% +$448K 2.67% 8
2023
Q4 		$6.81M Buy
43,973
+41
+0.1% +$5.98K 2.53% 7
2023
Q3 		$6.55M Sell
43,932
-135
-0.3% -$19.8K 2.62% 7
2023
Q2 		$5.94M Sell
44,067
-89
-0.2% -$13.1K 2.3% 8
2023
Q1 		$7.04M Sell
44,156
-47
-0.1% -$7.19K 2.87% 7
2022
Q4 		$7.14M Buy
44,203
+65
+0.1% +$9.97K 2.78% 7
2022
Q3 		$5.92M Hold
44,138
– – 2.53% 7
2022
Q2 		$6.76M Sell
44,138
-293
-0.7% -$44.8K 2.81% 6
2022
Q1 		$7.2M Hold
44,431
– – 2.62% 7
2021
Q4 		$6.02M Buy
+44,431
New +$5.25M 2.1% 8

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

High Net Worth Advisory Group's ABBV Position: Q1 2026 in Review

High Net Worth Advisory Group reduced its AbbVie (ABBV) stake by 0.13% in Q1 2026, selling an estimated $13.3K and leaving 45,441 shares worth $9.88M. The position accounts for 2.31% of the portfolio, ranked #8.

High Net Worth Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $10.5M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • High Net Worth Advisory Group held 45,441 shares of AbbVie worth $9.88M as of Q1 2026.
  • High Net Worth Advisory Group sold 60 AbbVie shares in Q1 2026, an estimated $13.3K.
  • AbbVie made up 2.31% of High Net Worth Advisory Group's portfolio in Q1 2026, its #8 holding.
  • High Net Worth Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • High Net Worth Advisory Group's AbbVie position peaked at $10.5M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on High Net Worth Advisory Group's 13F filing for Q1 2026, filed 17 Apr 2026.